Product Information
LAMIVUDINE 150 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.5901 per EA under NDC 31722075360. Its NADAC has been published 525 times since Jun 4, 2014.
Strength
150 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722075360
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA203277On Market Since
1/6/2014
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 150 MG TABLET has been published 525 times since Jun 4, 2014, and over the history we have for it it has declined 86.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5901 per EA |
|---|---|
| All-time high | $4.4389 (Jun 11, 2014) |
| All-time low | $0.4413 (Apr 17, 2024) |
| Median price | $1.0541 |
| Average price | $1.5258 |
| Largest weekly change | +54.1% (May 22, 2019) |
| Weeks tracked | 525 |
| Tracking since | Jun 4, 2014 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.5901 per EA (NDC 31722075360), effective Nov 13, 2024.
How has the price of LAMIVUDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 86.7%. It has been tracked across 525 weekly CMS publications since Jun 4, 2014.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?
Since Jun 4, 2014, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.4413 (Apr 17, 2024) to a high of $4.4389 (Jun 11, 2014), with a median of $1.0541 per EA.
Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LAMIVUDINE 150 MG TABLET, is $0.4602 per EA — about 22% below LAMIVUDINE 150 MG TABLET.
Who manufactures LAMIVUDINE 150 MG TABLET?
LAMIVUDINE 150 MG TABLET (NDC 31722075360) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification